CoChat

Long-acting preparations of exenatide

Open access
Yuan, Weien, Cai, Yunpeng, Liangming Wei, Liangming, Ma, Liuqing, Huang, Xiwen, Tao, Anqi, Liu, Zhenguo · 2013 · Drug Design, Development and Therapy
Cited by 57

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Exenatide has been widely used for the treatment of type 2 diabetes mellitus. However, its short plasma half-life of 2.4 hours has limited its clinical application. The exenatide products on the market, twice-daily Byetta™ and once-weekly Bydureon™ (both Amylin Pharmaceuticals, San Diego, CA, USA), are still not perfect. Many researchers have attempted to prolong the acting time of exenatide by preparing sustained-release dosage forms, modifying its structure, gene therapies, and other means. This review summarizes recent advances in long-acting exenatide preparations. Keywords: exendin-4, diabetes mellitus type 2, sustained release, long acting, extended release, microsphere

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/dddt.s46970

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 57

Metadata

Authors
Yuan, W., Cai, Y., Liangming Wei, L., Ma, L., Huang, X., Tao, A., & Liu, Z.
Venue
Drug Design, Development and Therapy
Published
2013-09
Volume
7
Pages
963
ISSN
1177-8881 (ISSN-L)
OpenAlex
W2157365347
Cited by
57
References
9
FWCI
1.42
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-acting preparations of exenatide. https://app.cochat.ai/papers/10.2147/dddt.s46970
The paper
Yuan, W., Cai, Y., Liangming Wei, L., Ma, L., Huang, X., Tao, A., & Liu, Z. (2013). Long-acting preparations of exenatide. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s46970

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.